/ /

Siegfried_Elaine-2.jpg
Elaine Siegfried, M.D.
Elaine Siegfried, M.D., is professor of pediatrics and dermatology, Saint Louis University Health Sciences Center, St. Louis, Mo. She also is a member of the Dermatology Times Editorial Advisory board and a co-medical editor.
Fake medical News
While pharmaceutical companies sponsor much credible medical education, mishandling of this opportunity can be a potent portal for fake news.
So many medications, so little access
Why are drugs so expensive? It’s complicated. Who is profiting? Not just "Big Pharma". Is there a solution to this problem? Only if everyone is willing to pay their fair share.
Know your worth: Advice for women in dermatology
Know your worth: Advice for women in dermatology
We sat down with Dr. Siegfried to talk more about her advice to young female dermatologists.
There ought to be a word
My interest in etymology, (not to be confused with entomology) has grown along with the importance of precise and efficient EMR documentation. Along the way, I learned some great words and acronyms and made up a few of my own.
Progress for Women in Medicine Slow, but Significant
Leadership roles for women in dermatology are increasing slowly but surely.
Weighing diagnosis with delivery
Read and follow along as Dr. Elaine Siegfried shares her insight into obsessive diagnosing disorder, and how it can be a blessing and a curse.
Should you wait after isotretinoin to treat acne with laser?
Dermatology Times editorial advisor, Dr. Elaine Siegfried continues the discussion on isotretinoin with Jim Leyden, M.D., emeritus professor of dermatology at the University of Pennsylvania. In this final segment, the two discuss whether a waiting period is necessary before treating acne scars and the questionable existence of pityrosporum folliculitis.
How to recognize sinus tracts, keratinous cysts
In part three of the discussion on isotretinoin, our experts discuss distinguishing sinus tracts or keratinous cysts from nodular areas of inflammation and techniques for treating via intralesional injection.
Isotretinoin dosing decisions
Dermatology Times editorial advisor, Dr. Elaine Siegfried continues the discussion on isotretinoin with James Leyden, M.D., emeritus professor of dermatology at the University of Pennsylvania. Here, the two discuss isotretinoin dosing and side effects.
Isotretinoin's discovery and development series
Dr. Jim Leyden, an active participant in isotretinoin's drug development process, discusses many of the important initial clinical observations and those that others have made over the years.

Poll

View Results